Physician profile
John M Lertora
NPI 1780657213
$4,398.07
in general payments reported to CMS, 2019-2025
18 companies · $556 in 2025
The $556 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,110 · 2020: $141 · 2021: $535 · 2022: $1,300 · 2023: $471 · 2024: $285 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,312.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $708.93 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $644.57 | 2023-2025 | Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $620.95 | 2019-2025 | Cequa |
| Allergan, INC. | $602.16 | 2019-2022 | |
| Oyster Point Pharma, INC. | $279.46 | 2022-2023 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $256.11 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $250.21 | 2019-2021 | |
| Alcon Vision LLC | $168.24 | 2020-2022 | |
| Shire North American Group INC | $153.87 | 2019 | |
| Abbvie INC. | $127.32 | 2022 | |
| Aerie Pharmaceuticals, INC. | $124.99 | 2019 | |
| Eyevance Pharmaceuticals LLC | $120.98 | 2021 | |
| Novo Nordisk INC | $106.30 | 2024 | Wegovy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $100.83 | 2019-2021 | |
| Lkc Technologies, INC. | $88.62 | 2022-2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $17.65 | 2022 | |
| Akorn Operating Company LLC | $15.25 | 2021 | |
| Coopervision INC. | $11.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lertora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.